Companies: 10,795·Total market cap: $144.5T
BioLife Sciences Inc.

BioLife Sciences Inc.

BLFEOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$156683
P/E Ratio
52W High$0.0001
52W Low$0.0001

BioLife Sciences Inc.(BLFE)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BLFE · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2020-112019-112018-112017-112016-11
Revenue
Revenue$0.41M$0.00M$0.00M$0.00M$0.00M
Cost of Revenue$1.40M$0.00M$0.00M$0.00M$0.00M
Gross Profit($0.98M)$0.00M$0.00M$0.00M$0.00M
Gross Margin %(computed)-239.25%
Operating Expenses
R&D Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses$0.26M$0.00M$0.04M$0.33M$0.01M
Operating Income($1.24M)$0.00M($0.04M)($0.33M)($0.01M)
Operating Margin %(computed)-302.17%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.05M$0.00M$0.01M$0.01M$0.01M
Income Before Tax($1.27M)($0.00M)($0.05M)($0.34M)($0.02M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($1.27M)($0.00M)($0.05M)($0.34M)($0.02M)
Net Margin %(computed)-307.99%
Per Share & EBITDA
EPS (Basic)$-0.02$-0.00$-0.00$-0.08$-0.05
Wtd Avg Shares51.78M19.45M19.45M4.45M0.42M
EBITDA($1.22M)$0.17M($0.04M)($0.33M)($0.01M)
EBITDA Margin %(computed)-295.95%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解BioLife Sciences Inc.

关于BioLife Sciences Inc.(BLFE)损益表

BioLife Sciences Inc.(BLFE)损益表数据来源于SEC Form 10-K及10-Q申报文件。2020财年,BLFE实现营收$0.00B,毛利润($0.00B)(毛利率-239.25%),净利润($0.00B)(净利率-307.99%)。

常见问题

BLFE · 4 问

BioLife Sciences Inc.(BLFE)2020财年营收为$0.00B,同比up—%。

BLFE revenueBLFE salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09